pyrazole has been researched along with Liver Steatosis in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, CYP2A5 expression during nonalcoholic fatty liver disease (NAFLD) is still unknown." | 1.39 | Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease. ( Cao, Y; Guo, G; Li, R; Liu, F; Wang, Y; Zhang, X, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R | 1 |
| Guo, G | 1 |
| Cao, Y | 1 |
| Wang, Y | 1 |
| Liu, F | 1 |
| Zhang, X | 1 |
1 other study available for pyrazole and Liver Steatosis
| Article | Year |
|---|---|
Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Diet, Hig | 2013 |